Conference abstract · 14 Mar 2022
Research articlePublished 8 Nov 2017
Efficacy of Ayurveda Formulation Ayush-82 (IME-9) in Newly Diagnosed Type 2 Diabetics: Retrospective Analysis of Individual Data
Research Officer (Ayurveda), Centralleal Ayurveda Research Institute of Hepatobiliary Disorders, Bharatpur, Bhubaneswar, CCRAS, M/O AYUSH, Govt Of India.; Central Ayurveda Research Institute of Hepatobiliary Disorders, Bharatpur, Bhubaneswar, Odisha, India
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Ayush 82 is formulated and clinically proven by Central Council Research in Ayurveda Sciences, M/o of AYUSH, GOI for diabetic care. Recently Right Sugar (Chaturbhuj Pharmaceutical), IME-9 (Kudos Ayurveda) and BGR-34 (AIMIL Pharmaceutical) have drawn the attention of many diabetic consumers as these products are developed from scientific organizations of government and highlighted in electronic and print media. IME-9 (Kudos Ayurveda) developed from Ayush 82 of Central Council Research in Ayurveda Sciences, M/o of AYUSH, GOI. Most of the patients consuming IME-9 attend Ayurvedic hospitals and clinics for evaluation of their blood sugar level to know the efficacy of the drug and for consultation. Therefore, an initiative was taken to analyze the safety and efficacy of IME-9 in newly diagnosed diabetic patients taking an IME-9 tablet or have a primary prescription of the same. IME-9 was able to reduce (96%) the blood glucose of all newly diagnosed cases, whereas glycosylated haemoglobin level was reduced in all newly diagnosed cases except in one. Total 12 (48%) patients have shown the improvement of blood glucose and glycosylated haemoglobin (up to 7). It is also observed that in three cases blood glucose level was increased after 2 weeks of treatment and significant reduction of blood glucose was found after the 8th week. So IME-9 may be the first line choice of herbal treatment of newly diagnosed cases along with a change in lifestyle.
Subjects
Alternative & Palliative CareAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Short communication · 28 May 2022
Management of newly diagnosed type 2 diabetes mellitus in ayurveda, a case report
Short communication · 31 Aug 2020
MANAGEMENT OF NEWLY DIAGNOSED TYPE 2 DIABETES MELLITUS IN AYURVEDA: A CASE REPORT
Conference abstract · 2020
Management of Newly diagnosed type 2 diabetes mellitus in Ayurveda, A Case Report
Short communication · 21 Feb 2022
Diabetic ketoacidosis in children and adolescents with newly diagnosed type 1 diabetes in Tigray, Ethiopia: Retrospective observational study
More from this journal
The newest in Journal of Traditional Medicine & Clinical Naturopathy.
Editorial · 23 Dec 2025
Herbal Medicine: Immunomodulation, Anti-inflammation, Therapeutic Potential
Short communication · 23 Dec 2025
Phytotherapy for Diabetes: Efficacy and Future Prospects
Commentary · 23 Dec 2025
Acupuncture: Effective, Safe Chronic Pain Management
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Traditional Medicine & Clinical Naturopathy
- SubjectAlternative & Palliative Care
- BylineArticles whose byline prints “Ashok Kumar Panda”
